Chen-Yuan Chiang1, Tauhid Islam2, Caihong Xu3, Thilaka Chinnayah4, Anna Marie Celina Garfin5, Kalpeshsinh Rahevar2, Mario Raviglione6. 1. International Union Against Tuberculosis and Lung Disease, Paris, France. 2. End TB and Leprosy Unit, Division of Programmes for Disease Control, WHO Regional Office for the Western Pacific, Manila, Philippines. 3. National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. 4. Tuberculosis and Leprosy Control Sector, Disease Control Division, Ministry of Health, Putrajaya, Malaysia. 5. Department of Health, Disease Prevention and Control Bureau, Manila, Philippines. 6. Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
To the Editor:We read with great interest the papers by Stochino
et al. [1], Tadolini
et al. [2] and Ong
et al. [3], which reported issues related to coronavirus disease 2019 (COVID-19) and tuberculosis (TB). The response to COVID-19, especially the lockdown of entire society, is likely to cause severe disruption of TB programmes [4-7]. Reduced TB case notifications have been reported from the top three high TB burden countries worldwide, raising concerns of un-interrupted TB transmission and increased TB mortality, thus posing the threat of derailing achievements made so far [4-7]. Furthermore, the process of post-lockdown restoration of TB services is important [7]. A slow restoration course may continue decreasing TB case finding as compared to a more rapid restoration time.To share the experience of national responses to the impact of COVID-19 on TB, the Western Pacific Regional Office of the World Health Organization coordinated an online meeting of the Technical Advisory Group on TB and National TB Programme Managers of the Region on 23–24 June 2020. There were more than 90 participants from 17 countries. Experiences in different countries were presented and strategies to address challenges of TB prevention and care in the era of COVID-19 were discussed.In China, non-medical interventions, including cancellation of public transportation, prohibition of public gathering and requirement for citizens to stay at home, have successfully brought COVID-19 under control [8-10]. However, these interventions have been associated with more than 20% reduction in national TB case detection in February 2020 compared with February 2019. A national survey on the impact of COVID-19 on TB found that restriction of traffic has created barriers for patients to access healthcare, difficulties for health providers in tracing presumptive TB cases, difficulties in sputum transportation, difficulties in ensuring TB patients' adherence to treatment, and challenges in visiting patients' households for contact tracing. Staff from national TB programmes, TB laboratories and TB wards have been re-assigned to the fight against COVID-19. Concern regarding COVID-19 transmission has reduced willingness of patients to visit health facilities. In response, online diagnosis and prescription of anti-TB medicines were introduced, independent TB wards were established to meet the need of TB patients, electronic means of treatment support was applied, health education to mitigate panic over COVID-19 was strengthened, procedures for testing for both COVID-19 and TB were developed, and personal protective equipment (PPE) for community health workers was provided.In Malaysia, border control, restriction of movement, social distancing and self-protection through PPE have resulted in a flattened COVID-19 incidence curve. However, these interventions have also caused a 9% reduction of TB case detection in January to May 2020 compared with that in 2019. To restore TB services, several new practices have been introduced, including online fast lane appointment for clinical visits, TB screening among COVID-19 cases, drive-through and dropbox for sputum collection and enhancing mobile chest radiography tools to avoid overcrowding in health facilities. Furthermore, physical distancing and use of PPE was advocated. Treatment support has been changed from facility-based to community-based to reduce patient' visits to health facilities. Continuous monitoring of national TB programmes and frequent reminders to implementers helped improve TB case detection and management.In the Philippines, community quarantine began in Manila on 15 March 2020, and subsequently was implemented in most parts of the country. Consequently, active TB case finding was discontinued; visits of symptomatic individuals to health facilities was restricted; priority of health services was shifted to COVID-19; GeneXpert platforms in selected TB culture laboratories were re-assigned to COVID-19 screening; and TB contact tracing was limited. The effect was an immediate decrease of 78.7% in aggregate weekly TB notification following community quarantine. To ensure continuity of TB services, the programme issued a memorandum that a 1-month supply of drugs should be given to patients and new standards will be issued through the national TB programme adaptive plan. Screening for TB was subjected to mandated social distancing and infection control procedures. Algorithm of handling specimens for TB testing in the community with ongoing transmission of COVID-19 was developed. Home based TB treatment by using digital adherence technologies has been introduced.After the presentations of China, Malaysia and the Philippines, participants were divided into three groups to discuss the impact of COVID-19, the opportunities and priorities for TB programmes. Response to COVID-19 has resulted in disruption of TB services and decreased detection of both active TB and latent TB infection in several countries [4]. Priority actions for rapid restoration of TB services from group discussions are summarised in table 1. While COVID-19 has imposed great challenges to national TB programmes, it has also created opportunities to develop innovative strategies to ensure continuity of TB services and ultimately to strengthen TB care, prevention and control.
TABLE 1
Priority for rapid restoration of tuberculosis (TB) care and prevention during the coronavirus disease 2019 (COVID-19) pandemic
Domains
Actions of priority
Case finding
Development of new standards of clinical consultations
Establishment of affordable online consultations for individuals with presumptive TB
Strengthening of specimen transportation using innovative approaches
Development of algorithm for dual TB and COVID-19 testing among individuals with respiratory symptoms
Application of digital platform and connectivity solutions for rapid delivery of test results
Strengthening of contact examinations during community quarantine for detection of active TB and management of latent TB infection
Treatment
Innovative approach for enrolment of bacteriologically confirmed TB cases on anti-TB treatment to prevent initial loss to follow-up
Strengthening of community-based TB treatment services to reduce health facility visits and prevent interruption of treatment
Scaling-up of digital adherence interventions, such as video directly observed therapy (VOT), short message services and innovative use of mobile applications
Establishment of digital mechanisms for the management of adverse reactions, especially for patients with rifampicin-resistant TB
Resources
Multi-sectorial approaches for restoration and enhancement of budget and human resources for TB prevention and care
Mobilisation of community health workers, civil society organisations and community-based organisations to strengthen response to both TB and COVID-19
Innovative approaches for training of health workers and health education of the community on TB and COVID-19 through digital platforms
Priority for rapid restoration of tuberculosis (TB) care and prevention during the coronavirus disease 2019 (COVID-19) pandemicDevelopment of new standards of clinical consultationsEstablishment of affordable online consultations for individuals with presumptive TBStrengthening of specimen transportation using innovative approachesDevelopment of algorithm for dual TB and COVID-19 testing among individuals with respiratory symptomsApplication of digital platform and connectivity solutions for rapid delivery of test resultsStrengthening of contact examinations during community quarantine for detection of active TB and management of latent TB infectionInnovative approach for enrolment of bacteriologically confirmed TB cases on anti-TB treatment to prevent initial loss to follow-upStrengthening of community-based TB treatment services to reduce health facility visits and prevent interruption of treatmentScaling-up of digital adherence interventions, such as video directly observed therapy (VOT), short message services and innovative use of mobile applicationsEstablishment of digital mechanisms for the management of adverse reactions, especially for patients with rifampicin-resistant TBMulti-sectorial approaches for restoration and enhancement of budget and human resources for TB prevention and careMobilisation of community health workers, civil society organisations and community-based organisations to strengthen response to both TB and COVID-19Innovative approaches for training of health workers and health education of the community on TB and COVID-19 through digital platformsThis one-page PDF can be shared freely online.Shareable PDF ERJ-03054-2020.Shareable
Authors: Catherine Wei Min Ong; Giovanni Battista Migliori; Mario Raviglione; Gavin MacGregor-Skinner; Giovanni Sotgiu; Jan-Willem Alffenaar; Simon Tiberi; Cornelia Adlhoch; Tonino Alonzi; Sophia Archuleta; Sergio Brusin; Emmanuelle Cambau; Maria Rosaria Capobianchi; Concetta Castilletti; Rosella Centis; Daniela M Cirillo; Lia D'Ambrosio; Giovanni Delogu; Susanna M R Esposito; Jose Figueroa; Jon S Friedland; Benjamin Choon Heng Ho; Giuseppe Ippolito; Mateja Jankovic; Hannah Yejin Kim; Senia Rosales Klintz; Csaba Ködmön; Eleonora Lalle; Yee Sin Leo; Chi-Chiu Leung; Anne-Grete Märtson; Mario Giovanni Melazzini; Saeid Najafi Fard; Pasi Penttinen; Linda Petrone; Elisa Petruccioli; Emanuele Pontali; Laura Saderi; Miguel Santin; Antonio Spanevello; Reinout van Crevel; Marieke J van der Werf; Dina Visca; Miguel Viveiros; Jean-Pierre Zellweger; Alimuddin Zumla; Delia Goletti Journal: Eur Respir J Date: 2020-10-01 Impact factor: 16.671
Authors: Huaiyu Tian; Yonghong Liu; Yidan Li; Chieh-Hsi Wu; Bin Chen; Moritz U G Kraemer; Bingying Li; Jun Cai; Bo Xu; Qiqi Yang; Ben Wang; Peng Yang; Yujun Cui; Yimeng Song; Pai Zheng; Quanyi Wang; Ottar N Bjornstad; Ruifu Yang; Bryan T Grenfell; Oliver G Pybus; Christopher Dye Journal: Science Date: 2020-03-31 Impact factor: 47.728
Authors: N Zokufa; K Lebelo; D Hacking; L Tabo; P Runeyi; N Malabi; S B Sibanda; T Cassidy; G Makanda; B Norman; S Khuzani; J Furin; C Jonker; B Nkasana; V Scott; C Pfaff Journal: Int J Tuberc Lung Dis Date: 2021-05-01 Impact factor: 2.373
Authors: Alexandra Jaye Zimmer; Joel Shyam Klinton; Charity Oga-Omenka; Petra Heitkamp; Carol Nawina Nyirenda; Jennifer Furin; Madhukar Pai Journal: J Epidemiol Community Health Date: 2021-09-17 Impact factor: 3.710
Authors: Pruthu Thekkur; Kudakwashe C Takarinda; Collins Timire; Charles Sandy; Tsitsi Apollo; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-31
Authors: Irene Mbithi; Pruthu Thekkur; Jeremiah Muhwa Chakaya; Elizabeth Onyango; Philip Owiti; Ngugi Catherine Njeri; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-10
Authors: Pruthu Thekkur; Hannock Tweya; Sam Phiri; James Mpunga; Thokozani Kalua; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-19